127 related articles for article (PubMed ID: 36069175)
1. Urachal carcinoma: A novel staging system utilizing the National Cancer Database.
Limonnik V; Samiei A; Abel S; Wegner RE; Vemana G; Mao SS
Cancer Med; 2023 Feb; 12(3):2752-2760. PubMed ID: 36069175
[TBL] [Abstract][Full Text] [Related]
2. Web-Based Prediction Models for Overall Survival and Cancer-Specific Survival of Patients With Primary Urachal Carcinoma: A Study Based on SEER Database.
Ding L; Xia B; Zhang Y; Liu Z; Wang J
Front Public Health; 2022; 10():870920. PubMed ID: 35719613
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for urachal cancer: a bayesian model-averaging approach.
Kim IK; Lee JY; Kwon JK; Park JJ; Cho KS; Ham WS; Hong SJ; Yang SC; Choi YD
Korean J Urol; 2014 Sep; 55(9):574-80. PubMed ID: 25237458
[TBL] [Abstract][Full Text] [Related]
4. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.
Ashley RA; Inman BA; Sebo TJ; Leibovich BC; Blute ML; Kwon ED; Zincke H
Cancer; 2006 Aug; 107(4):712-20. PubMed ID: 16826585
[TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of Novel Prediction Tools Based on Large Population-Based Database to Predict the Prognosis of Urachal Cancer After Surgery.
Yu X; Ma C; Wang M; Ying Y; Zhang Z; Ai X; Wang L; Zeng S; Xu C
Front Oncol; 2021; 11():718691. PubMed ID: 34595114
[TBL] [Abstract][Full Text] [Related]
6. TNM-Based Head-to-Head Comparison of Urachal Carcinoma and Urothelial Bladder Cancer: Stage-Matched Analysis of a Large Multicenter National Cohort.
Song SH; Lee J; Ko YH; Kim JW; Jung SI; Kang SH; Park J; Seo HK; Kim HJ; Jeong BC; Kim TH; Choi SY; Nam JK; Ku JY; Joo KJ; Jang WS; Yoon YE; Yun SJ; Hong SH; Oh JJ
Cancer Res Treat; 2023 Oct; 55(4):1337-1345. PubMed ID: 37080605
[TBL] [Abstract][Full Text] [Related]
7. Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases.
Szarvas T; Módos O; Niedworok C; Reis H; Szendröi A; Szász MA; Nyirády P
Urol Oncol; 2016 Sep; 34(9):388-98. PubMed ID: 27267737
[TBL] [Abstract][Full Text] [Related]
8. Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
Shao G; Xu C; Liu J; Li X; Li L; Li X; Zhang X; Fan Y; Zhou L
Urol Int; 2022; 106(2):199-208. PubMed ID: 34515250
[TBL] [Abstract][Full Text] [Related]
9. Urachal carcinoma: a pathologic and clinical study of 46 cases.
Dhillon J; Liang Y; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC
Hum Pathol; 2015 Dec; 46(12):1808-14. PubMed ID: 26364859
[TBL] [Abstract][Full Text] [Related]
10. Urachal carcinoma: Impact of recurrence pattern and lymphadenectomy on long-term outcomes.
Duan F; Zhai W; Zhang B; Guo S
Cancer Med; 2020 Jun; 9(12):4166-4174. PubMed ID: 32329250
[TBL] [Abstract][Full Text] [Related]
11. Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.
Molina JR; Quevedo JF; Furth AF; Richardson RL; Zincke H; Burch PA
Cancer; 2007 Dec; 110(11):2434-40. PubMed ID: 17932892
[TBL] [Abstract][Full Text] [Related]
12. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
Shang X; Liu J; Li Z; Lin J; Wang H
BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
[TBL] [Abstract][Full Text] [Related]
13. Prognostic influence for hilar cholangiocarcinoma and comparisons of prognostic values of Mayo staging and TNM staging systems.
Sun Z; Sun X; Guo J; Li X; Wang Q; Su N; Chen M; Cao G; Yu Y; Wang M; Li H; Zhong H; Zou H; Ma K; Shen F; Zhang B; Sun X; Feng Y
Medicine (Baltimore); 2022 Dec; 101(49):e32250. PubMed ID: 36626512
[TBL] [Abstract][Full Text] [Related]
14. Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance.
Módos O; Reis H; Niedworok C; Rübben H; Szendröi A; Szász MA; Tímár J; Baghy K; Kovalszky I; Golabek T; Chlosta P; Okon K; Peyronnet B; Mathieu R; Shariat SF; Hollósi P; Nyirády P; Szarvas T
Oncotarget; 2016 Jun; 7(26):39293-39301. PubMed ID: 27283768
[TBL] [Abstract][Full Text] [Related]
15. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
Bruins HM; Dorin RP; Rubino B; Miranda G; Cai J; Daneshmand S; Skinner EC
Eur Urol; 2012 Oct; 62(4):671-6. PubMed ID: 22575915
[TBL] [Abstract][Full Text] [Related]
16. Value of MRI in evaluating urachal carcinoma: A single center retrospective study.
Das JP; Woo S; Ghafoor S; Andrieu PIC; Ulaner GA; Donahue TF; Goh AC; Vargas HA
Urol Oncol; 2022 Jul; 40(7):345.e9-345.e17. PubMed ID: 35351368
[TBL] [Abstract][Full Text] [Related]
17. Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
Paner GP; Lopez-Beltran A; Sirohi D; Amin MB
Adv Anat Pathol; 2016 Mar; 23(2):71-83. PubMed ID: 26849813
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Mayo Clinic Staging System in Determining Prognoses of Patients With Perihilar Cholangiocarcinoma.
Coelen RJS; Gaspersz MP; Labeur TA; van Vugt JLA; van Dieren S; Willemssen FEJA; Nio CY; IJzermans JNM; Klümpen HJ; Groot Koerkamp B; van Gulik TM
Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1930-1939.e3. PubMed ID: 28532698
[TBL] [Abstract][Full Text] [Related]
19. Critical analysis of the 2010 TNM classification in patients with lymph node-positive bladder cancer: influence of lymph node disease burden.
Pedrosa JA; Kaimakliotis HZ; Monn MF; Cary KC; Masterson TA; Rice KR; Foster RS; Bihrle R; Koch MO; Cheng L
Urol Oncol; 2014 Oct; 32(7):1003-9. PubMed ID: 25027685
[TBL] [Abstract][Full Text] [Related]
20. The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up.
Yu YD; Ko YH; Kim JW; Jung SI; Kang SH; Park J; Seo HK; Kim HJ; Jeong BC; Kim TH; Choi SY; Nam JK; Ku JY; Joo KJ; Jang WS; Yoon YE; Yun SJ; Hong SH; Oh JJ
Front Oncol; 2021; 11():683190. PubMed ID: 34136407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
